Therapeutic Protein Kinase Inhibitors - Cellular and Molecular Life Sciences
- ️Grant, S. K.
- ️Mon Nov 17 2008
Abstract.
Protein kinase inhibitors represent an important and still emerging class of targeted therapeutic agents. Drug discovery and development strategies have explored numerous approaches to target the inhibition of protein kinase signaling. This review will highlight some of the strategies that have led to the successful clinical development of therapeutic protein kinase inhibitors, particularly as anticancer drugs. Some notable advances have been made in the development of novel protein and oligonucleotide-based biologics that target growth factor or receptor tyrosine kinases. Also, advances have been made in the rational design of small-molecule inhibitors that target unique kinase conformational forms and binding sites, and have specific kinase selectivity profiles. A review will also be given of some of the potential clinical toxicities and adverse side-effects associated with these kinase-targeted drugs. Therapeutic protein kinase inhibitors have been highly beneficial to cancer patients and offer the promise of future therapies for other diseases as well.
Access this article
Subscribe and save
- Get 10 units per month
- Download Article/Chapter or eBook
- 1 Unit = 1 Article or 1 Chapter
- Cancel anytime
Buy Now
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Instant access to the full article PDF.
Similar content being viewed by others
Author information
Authors and Affiliations
Department of Biochemical Pharmacology, Pfizer Global Research & Development, Pfizer La Jolla Laboratories, 10777 Science Center Drive, San Diego, CA, 92121, USA
S. K. Grant
Authors
- S. K. Grant
You can also search for this author in PubMed Google Scholar
Corresponding author
Correspondence to S. K. Grant.
Additional information
Received 02 September 2008; received after revision 13 October 2008; accepted 15 October 2008
Rights and permissions
About this article
Cite this article
Grant, S.K. Therapeutic Protein Kinase Inhibitors. Cell. Mol. Life Sci. 66, 1163–1177 (2009). https://doi.org/10.1007/s00018-008-8539-7
Published: 17 November 2008
Issue Date: April 2009
DOI: https://doi.org/10.1007/s00018-008-8539-7